Proton pump inhibitors in eosinophilic esophagitis (EoE) related to oral immunotherapy: is it as effective as in other EoE?

被引:1
|
作者
Shalem, Tzippora [1 ]
Cohen, Daniel L. [2 ]
Epstein-Rigbi, Na'ama [3 ,4 ]
Elizur, Arnon [3 ,4 ]
Eindor-Abarbanel, Adi [1 ]
Broide, Efrat [1 ,2 ,4 ]
Richter, Vered [2 ,4 ]
机构
[1] Shamir Assaf Harofeh Med Ctr, Jecheskiel Sigi Gonczarowski Pediat Gastroenterol, IL-70300 Zerifin, Israel
[2] Shamir Assaf Harofeh Med Ctr, Gonczarowski Family Inst Gastroenterol & Liver Dis, IL-70300 Zerifin, Israel
[3] Shamir Assaf Harofeh Med Ctr, Inst Allergy Immunol & Pediat Pulm, Zerifin, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
关键词
Eosinophilic esophagitis (EoE); Oral immunotherapy (OIT); Proton pump inhibitor (PPI); Treatment efficacy; ALLERGY;
D O I
10.1007/s00431-023-05228-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Oral immunotherapy (OIT) may induce eosinophilic esophagitis (EoE). Proton pump inhibitors (PPIs) are an effective treatment for EoE. However, the effect of PPI treatment is not well established in patients with EoE induced by OIT. Our primary aim was to compare the clinical, endoscopic, and histological response rates to PPIs in children with EoE induced by OIT (EoE+OIT) versus EoE patients without OIT (EoE-OIT). The secondary aims are to describe the clinical and histological features of EoE+OIT. Demographic, clinical, endoscopic, and histological findings of patients with EoE in the gastroenterology clinic at Shamir Medical Center between March 2015 and December 2022 were collected. Comparisons were performed between EoE+OIT and EoE-OIT patients. The study included 42 children (74% male, mean age 11.2), of whom 31 had EoE-OIT and 11 had EoE+OIT. There were no significant differences between groups regarding sex, comorbidities, symptoms, or endoscopic and histological characteristics at diagnosis. All 42 children were treated with PPIs after diagnosis with or without diet changes. The rates of any clinical response were 83.9% and 90.1% in the EoE-OIT group and EoE+OIT group, respectively (p = 1.0). The rate of any endoscopic response was 74.2% for EoE-OIT and 81.8% for EoE+OIT (p = 0.54). Histologically, PPIs were even more effective in the EoE+OIT group, where only 18.2% had no histological response at all compared to 51.6% in the EoE-OIT group (p = 0.1).Conclusion: PPI treatment is as effective in EoE with OIT as it is in EoE due to other etiologies.What is Known:& BULL; Proton pump inhibitor (PPI) treatment is effective for achieving clinical response and histologic remission in some patients with eosinophilic esophagitis (EoE).& BULL; EoE has also been reported to be triggered by oral immunotherapy (OIT).What is New:& BULL; PPI treatment in EoE with OIT is as effective as treatment for EoE due to other etiologies.
引用
收藏
页码:5409 / 5416
页数:8
相关论文
共 50 条
  • [41] Familial Risk of Eosinophilic Gastrointestinal Disorders (EGID) and Atopy in Eosinophilic Esophagitis (EoE)
    Peterson, Kathryn
    Fang, John C.
    Firszt, Rafael A.
    GASTROENTEROLOGY, 2015, 148 (04) : S414 - S414
  • [42] Genetic Analyses of Eosinophilic Esophagitis (EoE) Biopsies Does Not Explain the Rarity of EoE in Hispanics Compared to Caucasians Patients
    Naik, Pratik
    Yu, Christine
    McCallum, Richard
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S216 - S216
  • [43] Which Patients with Eosinophilic Esophagitis (EoE) Should Receive Elemental Diets Versus Other Therapies?
    Peterson K.A.
    Boynton K.K.
    Current Gastroenterology Reports, 2014, 16 (1)
  • [44] As Easy as EoE: A Novel and Effective Multidisciplinary Approach to Care of Patients with Eosinophilic Esophagitis in the Age of Biologics
    Chawla, Karan
    Alabbas, Bedoor
    Sheth, Dipa
    Papademetriou, Marianna
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (08) : 2196 - 2202
  • [45] As Easy as EoE: A Novel and Effective Multidisciplinary Approach to Care of Patients with Eosinophilic Esophagitis in the Age of Biologics
    Karan Chawla
    Bedoor Alabbas
    Dipa Sheth
    Marianna Papademetriou
    Digestive Diseases and Sciences, 2020, 65 : 2196 - 2202
  • [46] Resolution of Esophageal Remodeling Following Oral Viscous Budesonide (OVB) Therapy for Eosinophilic Esophagitis (EoE)
    Aceves, Seema
    Newbury, Robert O.
    Chen, Diana
    Broide, David
    Bastian, John F.
    Dohil, Ranjan
    GASTROENTEROLOGY, 2010, 138 (05) : S123 - S123
  • [47] Treatment With Proton Pump Inhibitors Is Effective in a Majority of Adults Patients With Eosinophilic Esophagitis
    Martinek, Jan
    Strosova, Alice
    Stefanova, Magdalena
    Tuckova, Inna
    Spicak, Julius
    GASTROENTEROLOGY, 2013, 144 (05) : S493 - S493
  • [48] Using Index of Severity for EoE to Guide Treatment for Patients With Eosinophilic Esophagitis
    Yu, Zhuo
    Arjonilla, Marta
    Monzur, Farah
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S364 - S365
  • [49] Treatment adherence in eosinophilic esophagitis (EoE): Patient, caregiver, and clinician perspectives
    Jaffee, Hannah
    Strobel, Mary Jo
    Chang, Joy
    Breich, Mark Hol-
    Medernach, Jonathan
    Eftekhari, Sanaz
    Greenhawt, Matthew
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02)
  • [50] Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy
    Petroni, Daniel
    Spergel, Jonathan M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (03) : 237 - +